Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, HOME BANCSHARES INC insiders sold a net $894.8K of stock across 71 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Oct 25, 2021.
The trade is 7.2% of the 209,617 shares held after it.
1 other insider sold within 30 days.
222 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Rankin Jim sold about $463.0K of HOMB on Aug 11, 2026; 1 other insider sold within 30 days and 222 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jun 20, 2025.
The trade is 15.7% of the 76,308 shares held after it.
1 other insider sold within 30 days.
222 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Centennial Bank CEO TIPTON JOHN STEPHEN sold about $379.1K of HOMB on Aug 4, 2026; 1 other insider sold within 30 days and 222 funds added in the latest 13F quarter.
7 earlier Form 4 trades (code P or S) here by this insider (6 buys, 1 sale), the last on Aug 26, 2025.
-1.3% median (-1.2% mean) 90-day return after 6 previous buys.
The trade is 1.7% of the 5,798,926 shares held after it.
No other insider bought within 30 days.
222 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman & CEO ALLISON JOHN W bought about $2.7M of HOMB on Apr 17, 2026, the largest insider purchase at the company on our record; 222 funds added in the latest 13F quarter.
71 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
HOMB planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Rankin Jim
Filed 2026-08-10
$473.1K
TIPTON JOHN STEPHEN
Filed 2026-08-04
$380.0K
HOMB mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
FAM SMALL CAP FUND
$11.5M position · as of 2026-06-30
3.7%
MML VIP American Century Small Company Value Fund
$1.3M position · as of 2026-06-30
2.2%
Nuveen Small Cap Value Opportunities Fund
$7.0M position · as of 2026-06-30
2.2%
Small Cap Value Fund
$65.5M position · as of 2026-06-30
2.2%
Small Cap Dividend Fund
$2.3M position · as of 2026-06-30
2.1%
Royce Small-Cap Total Return Fund
$19.8M position · as of 2026-06-30
2.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · John W. Allison
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$7.2M
$6.9M
$900.7K
+64%
+111%
2024
$6.2M
$7.2M
$2.1M
+63%
+65%
2023
$5.8M
$6.9M
$873.5K
+41%
+23%
2022
$5.7M
$5.2M
$2.1M
+23%
+13%
2021
$5.1M
$5.5M
$809.5K
+28%
+36%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $894.8K sold by insiders over 180 days, 222 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $853.1K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$429.9M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM HOMB
FY Dec 2025
$377.0M
FY Dec 2024
$422.1M
FY Dec 2023
$357.2M
FY Dec 2022
$393.6M
FY Dec 2021
$379.1M
Jun 2026
$94.1M
Mar 2026
$139.3M
Dec 2025
$84.2M
Sep 2025
$112.2M
Jun 2025
$70.4M
Mar 2025
$110.1M
Dec 2024
$60.9M
Sep 2024
$116.2M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on equity HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.37x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing HOMB
FY Dec 2025
11.48x
FY Dec 2024
14.08x
FY Dec 2023
12.99x
FY Dec 2022
14.33x
FY Dec 2021
12.55x
Jun 2026
11.75x
Mar 2026
11.04x
Dec 2025
11.48x
Sep 2025
12.25x
Jun 2025
13.06x
Mar 2025
13.53x
Dec 2024
14.08x
Sep 2024
13.96x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value HOMB
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.1%
TTM free cash flow over market value at close 2026-10-26
FCF yield HOMB
FY Dec 2025
+6.9%
FY Dec 2024
+7.5%
FY Dec 2023
+7.0%
FY Dec 2022
+8.5%
FY Dec 2021
+9.5%
Jun 2026
+7.5%
Mar 2026
+7.7%
Dec 2025
+6.9%
Sep 2025
+6.3%
Jun 2025
+6.4%
Mar 2025
+6.9%
Dec 2024
+7.5%
Sep 2024
+8.7%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.08x
P/E over trailing EPS growth of 11%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing HOMB
FY Dec 2025
0.56x
FY Dec 2024
4.58x
FY Dec 2023
0.57x
FY Dec 2022
n/a
FY Dec 2021
0.25x
Jun 2026
1.02x
Mar 2026
0.66x
Dec 2025
0.56x
Sep 2025
0.64x
Jun 2025
1.01x
Mar 2025
1.75x
Dec 2024
4.58x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
HOMB ranks highest on institutional and government (60th percentile) and risk and compliance (29th), and lowest on insider conviction (15th), among Banks peers.
Insider conviction
15
Inputs
Net Form 4 buying (codes P and S), 180d-$895K · 31 pct, sector of 273
Insider buyers, 180d0 · 0 pct, sector of 273
Institutional and government
60
Inputs
Funds adding, latest quarter222 · 82 pct, sector of 257
Congress net buyers, 365d0 · 38 pct, sector of 33
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
29
Inputs
Short interest, % of float+5.1% · 29 pct, sector of 374
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Profitability, Financial health, Growth, US patents
Profitability needs 2 of 4 inputs, 0 present: fewer than four consecutive quarters of net income; fewer than four consecutive quarters of operating income
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
HOMB filings, in plain words
Are Home Bancshares insiders buying or selling HOMB?
In the 180 days to 2026-10-28, Home Bancshares insiders were net sellers, a net $894.8K across purchases and sales reported on Form 4, by 3 sellers.
Have members of Congress traded HOMB?
Yes. In the year to 2026-10-28, 1 House member disclosed buying HOMB and 1 House member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31.
Are there planned insider sales of HOMB?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $853.1K of stock; the latest, by Rankin Jim, was filed 2026-08-10.
Read the full summary
In the 180 days to 2026-10-28, Home Bancshares insiders were net sellers of HOMB, a net $894.8K across purchases and sales reported on Form 4 by 3 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 1 member of Congress disclosed buying HOMB and 1 member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $853.1K of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.